Physician profile
Colleen E Glisson
NPI 1811181308
$1,107.94
in general payments reported to CMS, 2019-2025
8 companies · $69.20 in 2025
The $69.20 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $120 · 2021: $131 · 2022: $218 · 2023: $210 · 2024: $143 · 2025: $69.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $780.37 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $97.34 | 2024-2025 | Xiaflex |
| Elite Orthopedics, LLC | $85.28 | 2022 | |
| Acumed LLC | $73.64 | 2024 | Acumed |
| Molnlycke Health Care US, LLC | $18.34 | 2025 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Mepilex |
| Relievant Medsystems, INC. | $18.24 | 2023 | Intracept |
| Pacira Therapeutics, INC. | $17.62 | 2019 | |
| Boston Scientific Corporation | $17.11 | 2023 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Glisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.